Plain-English translation of NCT05456893 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Ulcerative Colitis research guide →Researchers are trying to find biological markers—measurable signs in your blood, stool, and tissue—that can predict which ulcerative colitis medications will work best for you before you start treatment, or very early on. By understanding these markers, doctors hope to offer truly personalized medicine: the right treatment for the right patient, rather than trial and error.
Currently, even with newer biologic therapies available, many people with ulcerative colitis don't get the relief they need because doctors can't predict in advance who will respond to which treatment. This study exists to find biological clues that will allow doctors to match patients with the medication most likely to help them.
You likely qualify if…
You likely don't qualify if…
You would visit the study center to provide blood and stool samples, and undergo an endoscopy (a procedure to look inside your colon) to assess your disease. The researchers would follow you over time as you receive your prescribed ulcerative colitis medication—this is an observational study, meaning they are watching and collecting data rather than assigning you to a specific new drug. You'll have follow-up visits where more samples are collected to see if the biological markers identified early on matched how well your treatment worked.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
France